Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40

View source ↗

Summary

A Marmara University clinical trial is examining whether the Qmax/eGFR ratio correlates with lower urinary tract symptom severity in men over 40, and the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Marmara University | Conditions: Lower Urinary Tract Symptom, Voiding Dysfunction | Status: NOT_YET_RECRUITING